Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ying Grace Li"'
Autor:
Charles Benson, Emmanuel Chigutsa, Amit Saxena, Paul Klekotka, Peter Chen, Gourab Datta, Ariel Kay, Josh Poorbaugh, Mark J. Mulligan, William A. Fischer, Ying Grace Li, Karen L. Price, Patricia Brown-Augsburger, Ajay Nirula, Robert J. Benschop, Nadine Rouphael, Jenny Y. Chien, Jeffrey Fill, Michael Dougan
Publikováno v:
Clinical Pharmacology and Therapeutics
Therapeutics for patients hospitalized with coronavirus disease 2019 (COVID-19) are urgently needed during the pandemic. Bamlanivimab is a potent neutralizing monoclonal antibody that blocks severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fc98bbcb8ce46dfce4862bd9a03be5
http://europepmc.org/articles/PMC8653186
http://europepmc.org/articles/PMC8653186
Autor:
Robin S. Scott, Charmian A. Quigley, Sreekumar G Pillai, Ying Grace Li, John S. Parks, Milton R. Brown, Poulabi Banerjee, Werner F. Blum
Publikováno v:
Hormone Research in Paediatrics. 91:164-174
Background/Aims: The term idiopathic short stature (ISS) describes short stature of unknown, but likely polygenic, etiology. This study aimed to identify genetic polymorphisms associated with the ISS phenotype, and with growth response to supplementa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba197e65b1865ff84e9a17c4c42b3b28
https://doi.org/10.1159/000496989
https://doi.org/10.1159/000496989
Autor:
Luis Nevárez Ruiz, Zvonko Milicevic, Zhuoxin Yu, Juan P. Frias, Ying Grace Li, David A. Cox, Brad Woodward
Publikováno v:
Journal of the Endocrine Society
Dulaglutide (DU) approved at doses of 0.75 and 1.5 mg once-weekly is an effective glucose lowering agent for treatment of type 2 diabetes (T2D). We hypothesized that higher investigational DU doses may provide further improvements in glucose control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6eb2512957573edadca3f3c48c14024
https://doi.org/10.1210/jendso/bvaa046.2057
https://doi.org/10.1210/jendso/bvaa046.2057
Autor:
Eloise E. Kaizar, Jason C. Hsu, Michael Man, Yi Liu, Stephen J. Ruberg, Szu-Yu Tang, Ying Grace Li
Publikováno v:
Statistics in Biopharmaceutical Research. 8:325-333
In personalized medicine, continuous biomarker values are often dichotomized to classify patients into target and nontarget populations. For example, baseline hemoglobin A1c (A1C) and Positive and Negative Syndrome Scale (PANSS) measurements are pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86cd417e7e20d40fe6672384a499b100
https://doi.org/10.1080/19466315.2016.1206486
https://doi.org/10.1080/19466315.2016.1206486
Publikováno v:
Ann. Appl. Stat. 12, no. 3 (2018), 1727-1748
Our research is for finding SNPs that are predictive of treatment efficacy, to decide which subgroup (with enhanced treatment efficacy) to target in drug development. Testing SNPs for lack of association with treatment outcome is inherently challengi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b196405aa01221ad7bd797c5ce6937a6
https://doi.org/10.1214/17-aoas1128
https://doi.org/10.1214/17-aoas1128
Autor:
Xiaoling Xuei, George J. Eckert, Mark A. Deeg, Ying Grace Li, Robert V. Considine, J. Howard Pratt
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821:381-385
HDL is a heterogeneous mixture of lipoprotein particles varying in composition, size, and function. We and others have described a small (7.0nm), minor (0.1% of total apolipoprotein AI) particle containing apolipoprotein AI, AIV and glycosylphosphati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cac0569d7adbde0efa5f6fcacbb425d
https://doi.org/10.1016/j.bbalip.2011.12.009
https://doi.org/10.1016/j.bbalip.2011.12.009
Autor:
Daniel E. Salazar, Joseph A. Jakubowski, David S Small, Ying Grace Li, John T. Brandt, Kenneth J. Winters, Christopher D. Payne, C. Steven Ernest, Nagy A. Farid
Publikováno v:
Journal of Cardiovascular Pharmacology. 50:555-562
Prasugrel pharmacodynamics and pharmacokinetics after a 60-mg loading dose (LD) and daily 10-mg maintenance doses (MD) were compared in a 3-way crossover study to clopidogrel 600-mg/75-mg and 300-mg/75-mg LD/MD in 41 healthy, aspirin-free subjects. E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8aeb4044a1bbe69362ebbc424a28311
https://doi.org/10.1097/fjc.0b013e3181492209
https://doi.org/10.1097/fjc.0b013e3181492209
Publikováno v:
Clinical pharmacology in drug development. 4(4)
LY500307 is a highly selective estrogen receptor β (ERβ) agonist, which loses its selectivity at high dose and leads to undesirable suppression of total testosterone (TT) concentration. The objective of the present analysis was to define the LY5003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20dfe7b8eecc4681ff926d60c8d284eb
https://pubmed.ncbi.nlm.nih.gov/27136911
https://pubmed.ncbi.nlm.nih.gov/27136911